Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.
Cash-strapped school boards, cities and legislatures scrounge to cover pay raises and pricey benefits and turn to teachers to fork over more of their shrinking take-home pay.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
New programs, known as ACOs, reward hospitals and physician groups that hold down costs by keeping enrollees healthy. The health care providers are asked to address social issues — such as homelessness, lack of transportation and poor nutrition — that can cause and exacerbate health problems.
Use Our Database For Your Reporting
Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration. But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups.
Sign Up For Our Email Newsletter
Stay informed by signing up for the KHN Morning Briefing and other emails: